1 Table of Contents: “...Mechanism of amino acid conjugation -- Forms of acyl-CoA synthetase medium-chain (ACSM) -- Activity...”

2 Table of Contents: “...Conjugative plasmids -- Original observation of conjugative transfer -- Description of transfer...”

3 Table of Contents: “...Antibody drug conjugates (ADCs) and their uses -- Different ways to measure ADCs in the cell...”

4 Table of Contents: “... components of conjugation -- The mating channel -- The complex between TrwC and its substrate DNA...”

5 Table of Contents: “...Chemistry: Synthesis and Characterization -- Enzymological Aspects of Steroid Conjugation...”

6 Table of Contents: “...How antibody-drug conjugates work -- How payloads are selected -- Methods for minimizing toxicity...”

7 Table of Contents: “...Contents: Modular composition of antibody drug conjugates -- ADC mode of action -- TWEAK receptor...”

8 Table of Contents: “...) -- After Glow NanoParticles (AG NPs) -- Solving low solubility of PpIX -- Conjugation of PpIX to AG NPs...”

9 Table of Contents: “... and their ability to fight AMR -- H. influenzae type b polysaccharide conjugate vaccines -- Pneumococcal...”

10 Table of Contents: “...The development of naked and drug-conjugated antibodies against endoglin and CD75b -- The results...”

11 Table of Contents: “... conjugates -- Continuing evolution of Multiple Myeloma treatment...”

12 Table of Contents: “...Phase II metabolism -- Conjugation of drugs and other xenobiotics with a range of different...”

13 Table of Contents: “... -- Prions inhibit proteasome function -- Binding of ubiquitin conjugates activate the 26S proteasome...”

14 Table of Contents: “...Ubiquity of plasmids -- The prokaryotic world -- Conjugation -- Common traits encoded by plasmids...”

15 Table of Contents: “... and T-cell lymphoma (antibody–drug conjugates)...”

16 Table of Contents: “... and individual level -- Drivers of multiple resistance -- Conjugate pneumococcal vaccine impact on antibiotic...”

17 Table of Contents: “... antibodies -- Antibody-drug conjugates -- Activation of EGFR by somatic mutation -- Kinase inhibitors -- MAPK...”

18 Table of Contents: “... - Xenobiotic and drug conjugation - Substrate specificities - Major groups SULT1 and SULT2 - Tissue-specific...”

19 Table of Contents: “... monoclonal antibodies -- Marketed therapeutic monoclonal antibodies -- Antibody-Drug Conjugates (ADC...”

20 Table of Contents: “... drug delivery -- Biological fate of polymeric nanocarriers -- The use of polymer-drug conjugates...”